http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110791468-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-01051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
filingDate 2019-10-14^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-11-23^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-11-23^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110791468-B
titleOfInvention Construction method and application of mycobacterium genetic engineering bacteria
abstract The invention discloses a construction method and application of a mycobacterium genetic engineering bacterium, belonging to the technical field of genetic engineering. After the recombinant plasmid is transformed into a mycobacterium LY-1 cell, sgRNA can recognize a specific region on a genome and guide Cas9 protein to be combined to a target site, and under the action of the protein, a gap of double-strand break is formed at the target site, and most cells die: the homologous repair sequence introduced with the recombinant plasmid is integrated to the gap through double exchange under the action of recombinase, so that cells successfully repaired by gene homology survive, and artificially designed genotypes such as gene inactivation, foreign gene insertion and the like are formed. The CRISPR-Cas9 system constructed by the invention has the knockout efficiency of 60% aiming at the same gene, and is more convenient and efficient compared with the existing mycobacteria gene editing mode.
priorityDate 2019-10-14^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-232167-A3
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491336
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192970
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426159225
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1785
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441336
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502241
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79154
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1785
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10425017

Showing number of triples: 1 to 34 of 34.